Downstream carcinogenesis signaling pathways by green tea polyphenols: A translational perspective of chemoprevention and treatment for cancers

Current Drug Metabolism

Volumn 15, Issue 1, 2014, Pages 14-22

  Hu, Guohua ^a   Zhang, Lei ^a   Rong, Yefei ^a   Ni, Xiaoling ^a   Sun, Yihong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Cancer; Chemoprevention; Green tea; Polyphenols; Treatment

Indexed keywords

EPIGALLOCATECHIN GALLATE; POLYPHENOL;

APOPTOSIS; BLADDER CANCER; BREAST CANCER; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE ARREST; CHEMOPROPHYLAXIS; COLON CANCER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE CANCER; LUNG CANCER; MOUTH CANCER; NEOPLASM; NONHUMAN; PROSTATE CANCER; REVIEW; SKIN CANCER; STOMACH CANCER; TEA; TUMOR CELL;

ANIMALS; ANTICARCINOGENIC AGENTS; CAMELLIA SINENSIS; CARCINOGENESIS; CATECHIN; HUMANS; NEOPLASMS; POLYPHENOLS; SIGNAL TRANSDUCTION;

EID: 84896344153     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/1389200214666131211155613     Document Type: Review

References (117)

1. Sang, S.; Lambert, J.D.; Ho, C.T.; Yang, C.S. The chemistry and biotransformation of tea constituents. Pharmacol. Res., 2011, 2, 87-99.
2. Greenberg, N.M.; DeMayo, F.; Finegold, M.J.; Medina, D.; Tilley, W.D.; Aspinall, J.O.; Cunha, G.R.; Donjacour, A.A.; Matusik, R.J.; Rosen, J.M. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. U. S. A., 1995, 8, 3439-3443.
3. Gupta, S.; Hastak, K.; Ahmad, N.; Lewin, J.S.; Mukhtar, H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. U. S. A., 2001, 18, 10350-10355.
4. Adhami, V.M.; Siddiqui, I.A.; Ahmad, N.; Gupta, S.; Mukhtar, H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res., 2004, 23, 8715-8722.
5. Saleem, M.; Adhami, V.M.; Ahmad, N.; Gupta, S., Mukhtar, H. Prognostic significance of metastasis-associated protein S100A4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model. Clin. Cancer Res., 2005, 1, 147-153.
6. Adhami, V.M.; Siddiqui, I.A.; Sarfaraz, S.; Khwaja, S.I.; Hafeez, B.B.; Ahmad, N.; Mukhtar, H. Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease. Clin. Cancer Res., 2009, 6, 1947-1953.
7. Liao, S.; Umekita, Y.; Guo, J; Kokontis, J.M.; Hiipakka, R.A. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett., 1995, 2, 239-243.
8. Liao, S., Hiipakka, R.A. Selective inhibition of steroid 5 alphareductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem Biophys Res Commun., 1995, 3, 833-838.
9. Zhou, J.R., Yu, L., Zhong, Y., Blackburn, G.L. Soy phytochemicals and tea bioactive components synergistically inhibit androgensensitive human prostate tumors in mice. J. Nutr., 2003, 2, 516-521.
10. Gupta, S.; Ahmad, N.; Mohan, R.R.; Husain, M.M.; Mukhtar, H. Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Cancer Res., 1999, 9, 2115-2120.
11. Roomi, M.W.; Ivanov, V.; Kalinovsky, T.; Niedzwiecki, A.; Rath, M. In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human prostate cancer PC-3 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry. In vivo., 2005, 1, 179-183.
12. Giovannucci, E., Michaud, D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology, 2007, 6, 2208-2225.
13. El-Serag, H.B., Rudolph, K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 2007, 7, 2557-2576.
14. Alexia, C.; Fallot, G.; Lasfer, M.; Schweizer-Groyer, G.; Groyer, A. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis. Biochem. Pharmacol., 2004, 6, 1003-1015.
15. Durai, R.; Yang. W.; Gupta, S.; Seifalian, A.M.; Winslet, M.C. The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge. Int. J. Colorectal. Dis., 2005, 3, 203-220.
16. Lin, J.K.; Lin-Shiau, S.Y. Mechanisms of hypolipidemic and antiobesity effects of tea and tea polyphenols. Mol. Nutr. Food Res., 2006, 2, 211-217.
17. Wolfram, S.; Raederstorff, D.; Wang, Y.; Teixeira, S.R.; Elste, V.; Weber, P. TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass. Ann. Nutr. Metab., 2005, 1, 54-63.
18. Shimizu, M.; Shirakami, Y.; Sakai, H.; Adachi, S.; Hata, K.; Hirose, Y.; Tsurumi, H.; Tanaka, T.; Moriwaki, H. (-)- Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice. Cancer Prev. Res. (Phila)., 2008, 4, 298-304.
19. Ju, J.; Liu, Y.; Hong, J.; Huang, M.T.; Conney, A.H.; Yang, C.S. Effects of green tea and high-fat diet on arachidonic acid metabolism and aberrant crypt foci formation in an azoxymethaneinduced colon carcinogenesis mouse model. Nutr. Cancer, 2003, 2, 172-178.
20. Shimizu, M.; Sakai, H.; Shirakami, Y.; Yasuda, Y.; Kubota, M.; Terakura, D.; Baba, A.; Ohno, T.; Hara, Y.; Tanaka, T.; Moriwaki, H. Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice. Cancer Prev. Res. (Phila)., 2011, 3, 396-403.
21. Powell, S.M.; Zilz N.; Beazer-Barclay, Y.; Bryan, T.M.; Hamilton S.R.; Thibodeau, S.N.; Vogelstein, B.; Kinzler, K.W. APC mutations occur early during colorectal tumorigenesis. Nature, 1992, 6392, 235-237.
22. Morin, P.J.; Sparks, A.B.; Korinek, V.; Barker, N.; Clevers, H.; Vogelstein, B.; Kinzler, K.W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science, 1997, 5307, 1787-1790.
23. Ju, J.; Hong J.; Zhou, J.N.; Pan, Z.; Bose, M.; Liao, J.; Yang, G.Y.; Liu, Y.Y.; Hou, Z.; Lin, Y.; Ma, J.; Shih, W.J.; Carothers, A.M. Yang, C.S. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin- 3-gallate, the major catechin in green tea. Cancer Resv., 2005, 22, 10623-10631.
24. Volate, S.R.; Muga, S.J.; Issa, A.Y.; Nitcheva, D.; Smith, T.; Wargovich, M.J. Epigenetic modulation of the retinoid X receptor alpha by green tea in the azoxymethane-Apc Min/+ mouse model of intestinal cancer. Mol. Carcinog., 2009, 10, 920-933.
25. Sartippour, M.R.; Heber, D.; Ma, J.; Lu, Q.; Go, V.L.; Nguyen, M. Green tea and its catechins inhibit breast cancer xenografts. Nutr. Cancer, 2001, 2, 149-156.
26. Kavanagh, K.T.; Hafer, L.J.; Kim, D.W.; Mann, K.K.; Sherr, D.H.; Rogers, A.E. Sonenshein G.E. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J. Cell Biochem., 2001, 3, 387-398.
27. Yanaga, H.; Fujii, T.; Koga, T.; Araki, R.; Shirouzu, K. Prevention of carcinogenesis of mouse mammary epithelial cells RIII/MG by epigallocatechin gallate. Int. J. Mol. Med., 2012, 3, 311-315.
28. Lu, G.; Liao, J.; Yang, G.; Reuhl, K.R.; Hao, X.; Yang, C.S. Inhibition of adenoma progression to adenocarcinoma in a 4- (methylnitrosamino)-1-(3- pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. Cancer Res., 2006, 23, 11494-11501.
29. Sagara, Y.; Miyata, Y.; Nomata, K.; Hayashi, T.; Kanetake, H. Green tea polyphenol suppresses tumor invasion and angiogenesis in N-butyl-(-4- hydroxybutyl) nitrosamine-induced bladder cancer. Cancer Epidemiol., 2010, 3, 350-354.
30. Srinivasan, P.; Suchalatha, S.; Babu, P.V.; Devi, R.S.; Narayan, S.; Sabitha, K.E.; Shyamala, Devi, C.S. Chemopreventive and therapeutic modulation of green tea polyphenols on drug metabolizing enzymes in 4-Nitroquinoline 1-oxide induced oral cancer. Chem. Biol. Interact., 2008, 3, 224-234.
31. Huang, M.T.; Ho, C.T.; Wang, Z.Y.; Ferraro, T.; Finnegan-Olive, T.; Lou, Y.R.; Mitchell, J.M.; Laskin, J.D.; Newmark, H.; Yang, C.S., et al. Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis, 1992, 6, 947-954.
32. Katiyar, S.K.; Agarwal, R.; Wood, G.S.; Mukhtar, H. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in 7, 12-dimethylbenz[a]anthracene-initiated SENCAR mouse skin by a polyphenolic fraction isolated from green tea. Cancer Res., 1992, 24, 6890-6897.
33. Wang, Z.Y.; Huang, M.T.; Ferraro, T.; Wong, C.Q.; Lou, Y.R.; Reuhl, K.; Iatropoulos, M.; Yang, C.S.; Conney, A.H. Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O- tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice. Cancer Res., 1992, 5, 1162-1170.
34. Lu, Y.P.; Lou, Y.R.; Xie, J.G.; Peng, Q.Y.; Liao, J.; Yang, C.S.; Huang, M.T.; Conney, A.H. Topical applications of caffeine or (-)- epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc. Natl. Acad. Sci. U. S. A., 2002, 19, 12455-12460.
35. Mantena, S.K.; Meeran, S.M.; Elmets, C.A.; Katiyar, S.K. Orally administered green tea polyphenols prevent ultraviolet radiationinduced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors. J. Nutr., 2005, 12, 2871-2877.
36. McCubrey, J.A.; Steelman, L.S.; Abrams, S.L.; Bertrand, F.E.; Ludwig, D.E.; Basecke, J.; Libra, M.; Stivala, F.; Milella, M.; Tafuri, A.; Lunghi, P.; Bonati, A.; Martelli, A.M. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. Leukemia, 2008, 4, 708-722.
37. Downward, J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer, 2003, 1, 11-22.
38. Marais, R.; Light, Y.; Paterson, H.F.; Marshall, C.J. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO, J., 1995, 13, 3136-3145.
39. Franke, T.F.; Kaplan, D.R.; Cantley, L.C.; Toker, A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3, 4-bisphosphate. Science, 1997, 5300, 665-668.
40. Alessi, D.R.; James, S.R.; Downes, C.P.; Holmes, A.B.; Gaffney, P.R.; Reese, C.B.; Cohen, P. Characterization of a 3- phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol., 1997, 4, 261-269.
41. Martelli, A.M.; Evangelisti, C.; Chiarini, F.; McCubrey, J.A. The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients. Oncotarget., 2010, 2, 89-103.
42. Du, K.; Montminy, M. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem., 1998, 49, 32377-32379.
43. Kane, L.P.; Shapiro, V.S.; Stokoe, D.; Weiss, A. Induction of NFkappaB by the Akt/PKB kinase. Curr. Biol., 1999, 11, 601-604.
44. Martelli, A.M.; Evangelisti, C.; Chiarini, F.; Grimaldi, C.; Cappellini, A.; Ognibene, A.; McCubrey, J.A. The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis. Biochim. Biophys. Acta, 2010, 9, 991-1002.
45. Del Peso, L.; Gonzalez-Garcia, M.; Page, C.; Herrera, R.; Nunez, G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science, 1997, 533, 687-689.
46. Cross, D.A.; Alessi, D.R.; Cohen, P.; Andjelkovich, M.; Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature, 1995, 6559, 785-789.
47. Chalhoub, N.; Baker, S.J. PTEN and the PI3-kinase pathway in cancer. Annu. Rev. Pathol., 2009, 4, 127-150.
48. Lioubin, M.N.; Algate, P.A.; Tsai, S.; Carlberg, K.; Aebersold, A.; Rohrschneider, L.R. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev., 1996, 9, 1084-1095.
49. Muraille, E.; Pesesse, X.; Kuntz, C.; Erneux, C. Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells. Biochem. J., 1999, 342 (Pt 3) 697-705.
50. Vallabhapurapu, S.; Karin, M. Regulation and function of NFkappaB transcription factors in the immune system. Annu. Rev. Immunol., 2009, 27, 693-733.
51. Jeong, S.J.; Radonovich, M.; Brady, J.N.; Pise-Masison, C.A. HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity. Blood, 2004, 5, 1490-1497.
52. Scortegagna, M.; Cataisson, C.; Martin, R.J.; Hicklin, D.J.; Schreiber, R.D.; Yuspa, S.H.; Arbeit, J.M. HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling. Blood, 2008, 7, 3343-3354.
53. Deng, J.; Miller, S.A.; Wang, H.Y.; Xia, W.; Wen, Y.; Zhou, B.P. Li, Y.; Lin, S.Y.; Hung, M.C. beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell, 2002, 4, 323-334.
54. Saltiel, A.R.; Kahn, C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 2001, 6865, 799-806.
55. Jones, J.I.; Clemmons, D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev., 1995, 1, 3-34.
56. Boccaccio, C.; Comoglio, P.M. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat. Rev. Cancer., 2006, 8, 637-645.
57. Kanayama, M.; Takahara, T.; Yata, Y.; Xue, F.; Shinno, E.; Nonome, K.; Kudo, H.; Kawai, K.; Kudo, T.; Tabuchi, Y.; Watanabe, A.; Sugiyama, T. Hepatocyte growth factor promotes colonic epithelial regeneration via Akt signaling. Am. J. Physiol. Gastrointest. Liver Physiol., 2007, 1, G230-239.
58. Sheng, H.; Shao, J.; Dixon, D.A.; Williams, C.S.; Prescott, S.M.; DuBois, R.N.; Beauchamp, R.D. Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J. Biol. Chem., 2000, 9, 6628-6635.
59. Ristimaki, A. Cyclooxygenase 2: from inflammation to carcinogenesis. Novartis Found Symp., 2004, 215-221, discussion 221-216, 259-269.
60. Sheng, H.; Shao J.; Dubois, R.N. K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. Cancer Res., 2001, 6, 2670-2675.
61. Kaelin, W.G. Jr.; Ratcliffe, P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell, 2008, 4, 393-402.
62. Semenza, G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer, 2003, 10, 721-732.
63. Vernon, A.E.;, LaBonne C. Tumor metastasis: a new twist on epithelial-mesenchymal transitions. Curr. Biol., 2004, 17, R719-721.
64. Visse, R.; Nagase, H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res., 2003, 8, 827-839.
65. Klein, G.; Vellenga, E.; Fraaije, M.W.; Kamps, W.A.; de Bont, E.S. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit. Rev. Oncol. Hematol., 2004, 2, 87-100.
66. Oliner, J.D.; Pietenpol, J.A.; Thiagalingam, S.; Gyuris, J.; Kinzler, K.W.; Vogelstein, B. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature, 1993, 6423, 857-860.
67. Honda, R.; Yasuda, H. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene, 2000, 11, 1473-1476.
68. Mirzayans, R.; Andrais, B.; Scott, A.; Murray, D. New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy. J Biomed. Biotechnol., 2012, 170325.
69. Wang, B.; Xiao, Z.; Ko, H.L.; Ren, E.C. The p53 response element and transcriptional repression. Cell Cycle, 2010, 5, 870-879.
70. McCubrey, J.A.; Steelman, L.S.; Chappell, W.H.; Abrams, S.L.; Wong, E.W.; Chang, F.; Lehmann, B.; Terrian, D.M.; Milella, M.; Tafuri, A.; Stivala, F.; Libra, M.; Basecke, J.; Evangelisti, C.; Martelli, A.M.; Franklin, R.A. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim. Biophys. Acta, 2007, 8, 1263-1284.
71. McCubrey, J.A.; Lahair, M.M.; Franklin, R.A. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid. Redox. Signal., 2006, 9-10, 1775-1789.
72. St-Germain, M.E.; Gagnon, V.; Parent, S.; Asselin, E. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway. Mol. Cancer, 2004, 7.
73. Son, Y.O.; Pratheeshkumar, P.; Wang, L.; Wang, X.; Fan, J.; Kim, D.H.; Lee, J.Y.; Zhang, Z.; Lee, J.C.; Shi, X. Reactive oxygen species mediate Cr(VI)-induced carcinogenesis through PI3K/AKT-dependent activation of GSK-3beta/beta-catenin signaling. Toxicol. Appl. Pharmacol., 2013, 2, 239-248.
74. Siddiqui, I.A.; Adhami, V.M.; Afaq, F.; Ahmad, N.; Mukhtar, H. Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. J. Cell Biochem., 2004, 2, 232-242.
75. McLarty, J.; Bigelow R.L.; Smith, M.; Elmajian, D.; Ankem, M.; Cardelli, J.A. Tea polyphenols decrease serum levels of prostatespecific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev. Res. (Phila)., 2009, 7, 673-682.
76. Duhon, D.;; Bigelow, R.L. Coleman, D.T.; Steffan, J.J.; Yu, C. Langston, W.; Kevil, C.G.; Cardelli, J.A. The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells. Mol. Carcinog., 2010, 8, 739-749.
77. Kazi, A.; Smith, D.M.; Zhong, Q.; Dou, Q.P. Inhibition of bcl-x(l) phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosis. Mol. Pharmacol., 2002, 4, 765-771.
78. Siddiqui, I.A.; Shukla, Y.; Adhami, V.M.; Sarfaraz, S.; Asim, M.; Hafeez, B.B.; Mukhtar, H. Suppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model. Pharm. Res., 2008, 9, 2135-2142.
79. Hagen, R.M.; Chedea, V.S.; Mintoff, C.P.; Bowler, E.; Morse, H.R.; Ladomery, M.R. Epigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3 prostate cancer cells. Int. J. Oncol., 2013, 1, 194-200.
80. Gupta, K.; Thakur, V.S.; Bhaskaran, N.; Nawab, A.; Babcook, M.A.; Jackson, M.W.; Gupta, S. Green tea polyphenols induce p53- dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanisms. PLoS One, 2012, 12, e52572.
81. Ren, F.; Zhang, S.; Mitchell, S.H.; Butler, R.; Young, C.Y. Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells. Oncogene, 2000, 15, 1924-1932.
82. Siddiqui, I.A.; Asim, M.; Hafeez, B.B.; Adhami, V.M.; Tarapore, R.S.; Mukhtar, H. Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J., 2011, 4, 1198-1207.
83. Larsen, C.A.; Dashwood, R.H. (-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells. Arch. Biochem. Biophys., 2010, 1, 52-57.
84. Shimizu, M.; Shirakami, Y.; Sakai, H.; Yasuda, Y.; Kubota, M.; Adachi, S.; Tsurumi, H.; Hara, Y.; Moriwaki, H. (-)- Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells. Chem. Biol. Interact., 2010, 3, 247-252.
85. Liu, S.; Wang, X.J.; Liu, Y.; Cui, Y.F. PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells. Am. J. Chin. Med., 2013, 3, 629-642.
86. Zhu, Z.; Wang, Y.; Liu, Z.; Wang, F.; Zhao, Q. Inhibitory effects of epigallocatechin-3-gallate on cell proliferation and the expression of HIF-1alpha and P-gp in the human pancreatic carcinoma cell line PANC-1. Oncol. Rep., 2012, 5, 1567-1572.
87. Kim, S.O.; Kim, M.R. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity. Int. J. Oncol., 2013, 1, 349-358.
88. Zhang, L.; Pang, E.; Loo, R.R.; Rao, J.; Go, V.L.; Loo, J.A.; Lu, Q.Y. Concomitant inhibition of HSP90, its mitochondrial localized homologue TRAP1 and HSP27 by green tea in pancreatic cancer HPAF-II cells. Proteomics, 2011, 24, 4638-4647.
89. Tanaka, T.; Ishii, T.; Mizuno, D.; Mori, T.; Yamaji R.; Nakamura, Y.; Kumazawa, S.; Nakayama, T.; Akagawa, M. (-)- Epigallocatechin-3-gallate suppresses growth of AZ521 human gastric cancer cells by targeting the DEAD-box RNA helicase p68. Free Radic. Biol. Med., 2011, 10, 1324-1335.
90. Onoda, C.; Kuribayashi, K.; Nirasawa, S.; Tsuji, N.; Tanaka, M.; Kobayashi, D.; Watanabe, N. (-)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression. Int. J. Oncol., 2011, 5, 1403-1408.
91. Huang, W.; Ding, L.; Huang, Q.; Hu, H.; Liu, S.; Yang, X.; Hu, X.; Dang, Y.; Shen, S.; Li, J.; Ji, X.; Jiang, S.; Liu, J.O.; Yu, L. Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma. Hepatology, 2010, 2, 703-714.
92. Slivova, V.; Zaloga, G.; DeMichele, S.J.; Mukerji, P.; Huang, Y.S.; Siddiqui, R.; Harvey, K.; Valachovicova, T.; Sliva, D. Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells. Nutr. Cancer, 2005, 1, 66-73.
93. Sen, T.; Chatterjee, A. Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor alpha5beta1 in the process. Eur. J. Nutrv., 2011, 6, 465-478.
94. Sen, T.; Dutta, A.; Chatterjee, A. Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231. Anticancer Drugs, 2010, 6, 632-644.
95. Thangapazham, R.L.; Singh, A.K.; Sharma, A.; Warren, J.; Gaddipati, J.P.; Maheshwari, R.K. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett., 2007, 1-2, 232-241.
96. Farabegoli, F.; Papi, A.; Orlandi M. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. Biosci. Rep., 2011, 2, 99-108.
97. Zhang, Y.; Han, G.; Fan, B.; Zhou, Y.; Zhou, X.; Wei, L.; Zhang, J. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity. Eur. J. Pharmacol., 2009, 1-3, 172-179.
98. Tran, P.L.; Kim, S.A.; Choi, H.S.; Yoon, J.H.; Ahn, S.G. Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo. BMC Cancer, 2010, 10, 276.
99. De Amicis, F.; Russo, A.; Avena, P.; Santoro, M.; Vivacqua, A.; Bonofiglio, D., Mauro L., Aquila S., Tramontano D., Fuqua S.A., Ando S. In vitro mechanism for downregulation of ER-alpha expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells. Mol. Nutr. Food Res., 2013, 5, 840-853.
100. Hsu, Y.C.; Liou, Y.M. The anti-cancer effects of (-)- epigallocatechin-3-gallate on the signaling pathways associated with membrane receptors in MCF-7 cells. J. Cell Physiol., 2011, 10, 2721-2730.
101. Zhang, G.; Wang, Y.; Zhang, Y.; Wan, X.; Li, J.; Liu, K.; Wang, F.; Liu, Q.; Yang, C.; Yu, P.; Huang, Y.; Wang, S.; Jiang, P.; Qu, Z.; Luan, J.; Duan, H.; Zhang, L.; Hou, A.; Jin, S.; Hsieh, T.C.; Wu, E. Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy. Curr. Mol. Med., 2012, 2, 163-176.
102. Yamauchi, R., Sasaki K., Yoshida K. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549. Toxicol. In vitro., 2009, 5, 834-839.
103. Jin, L.; Li, C.; Xu, Y.; Wang, L.; Liu, J.; Wang, D.; Hong, C.; Jiang, Z.; Ma, Y.; Chen, Q.; Yu, F. Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells. Oncol. Rep., 2013, 5, 1983-1990.
104. Lu, Q.Y.; Jin, Y.; Mao, J.T.; Zhang, Z.F.; Heber, D.; Dubinett, S.M.; Rao, J. Green tea inhibits cycolooxygenase-2 in non-small cell lung cancer cells through the induction of Annexin-1. Biochem. Biophys. Res. Commun., 2012, 4, 725-730.
105. He, L., Zhang E., Shi J., Li X., Zhou K., Zhang Q., Le A.D., Tang X. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1alpha. Cancer Chemother Pharmacol., 2013, 3, 713-725.
106. Wang, H.; Bian, S.; Yang, C.S. Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1alpha. Carcinogenesis, 2011, 12, 1881-1889.
107. Hessien, M.; El-Gendy, S.; Donia, T.; Sikkena, M.A. Growth inhibition of human non-small lung cancer cells h460 by green tea and ginger polyphenols. Anticancer Agents Med. Chem., 2012, 4, 383-390.
108. Kwak, I.H.; Shin, Y.H.; Kim, M.; Cha, H.Y.; Nam, H.J.; Lee, B.S.; Chaudhary, S.C.; Pai, K.S.; Lee, J.H. Epigallocatechin-3-gallate inhibits paracrine and autocrine hepatocyte growth factor/scatter factor-induced tumor cell migration and invasion. Exp. Mol. Med., 2011, 2, 111-120.
109. Ellis, L.Z.; Liu, W.; Luo, Y.; Okamoto, M.; Qu, D.; Dunn, J.H.; Fujita, M. Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL- 1beta secretion. Biochem. Biophys. Res. Commun., 2011, 3, 551-556.
110. Nandakumar, V.; Vaid, M.; Katiyar, S.K. (-)-Epigallocatechin-3- gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis, 2011, 4, 537-544.
111. Mittal, A.; Piyathilake, C.; Hara, Y.; Katiyar, S.K. Exceptionally high protection of photocarcinogenesis by topical application of (-)- epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia, 2003, 6, 555-565.
112. Qin, J.; Wang, Y.; Bai, Y.; Yang, K.; Mao, Q.; Lin, Y.; Kong, D.; Zheng, X.; Xie, L. Epigallocatechin-3-gallate inhibits bladder cancer cell invasion via suppression of NF-kappaBmediated matrix metalloproteinase-9 expression. Mol. Med. Rep., 2012, 5, 1040-1044.
113. Singh, M.; Singh, R.; Bhui, K.; Tyagi, S.; Mahmood, Z.; Shukla, Y. Tea polyphenols induce apoptosis through mitochondrial pathway and by inhibiting nuclear factor-kappaB and Akt activation in human cervical cancer cells. Oncol Res., 2011, 6, 245-257.
114. Zou, C.; Liu, H.; Feugang, J.M.; Hao, Z.; Chow, H.H.; Garcia, F. Green tea compound in chemoprevention of cervical cancer. Int. J. Gynecol. Cancer., 2010, 4, 617-624.
115. Sharma, C.; Nusri, Qel A.; Begum, S.; Javed, E.; Rizvi, T.A.; Hussain, A. (-)-Epigallocatechin-3-gallate induces apoptosis and inhibits invasion and migration of human cervical cancer cells. Asian Pac. J. Cancer Prev., 2012, 9, 4815-4822.
116. De Amicis, F.; Perri, A.; Vizza, D.; Russo, A.; Panno, M.L.; Bonofiglio, D.; Giordano, C.; Mauro, L.; Aquila, S.; Tramontano D.; Ando, S. Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines. J. Cell Physiol., 2013, 10, 2054-2062.
117. Lim, Y.C.; Cha, Y.Y. Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex. J. Surg. Oncol., 2011, 7, 776-780.